|
|
| (5 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | {{Details0|Cefuroxime axetil (oral)}} |
| {{Cefuroxime}} | | {{Details0|Cefuroxime sodium (injection)}} |
| {{CMG}};{{AE}}{{AK}} | |
| | |
| ==Overview==
| |
| Cefuroxime is a parenteral second-generation cephalosporin antibiotic. This antibiotic was discovered by the Glaxo company, now GlaxoSmithKline, and it was first marketed in 1978 as Zinacef. Zinacef was approved by the U.S. Food and Drug Administration on Oct 19, 1983. The generic form of cefuroxime is also called "Ceftin". The 17-year patent for this antibiotic has now expired in the United States, hence the patent "rights" to produce this medication are now irrelevant.
| |
| | |
| In the United States this antibiotic is also sold as "Zinacef" by Covis Pharmaceuticals
| |
| | |
| ==Category==
| |
| | |
| [[Cephalosporins]], second generation.
| |
| | |
| ==US Brand Names==
| |
| | |
| CEFUROXIME<sup>®</sup>,ZINACEF<sup>®</sup>,KEFUROX<sup>®</sup>
| |
| | |
| | |
| | |
| ==FDA Package Insert==
| |
| '''[[Cefuroxime description|Description]]'''
| |
| '''| [[Cefuroxime clinical pharmacology|Clinical Pharmacology]]'''
| |
| '''| [[Cefuroxime microbiology|Microbiology]]'''
| |
| '''| [[Cefuroxime indications and usage|Indications and Usage]]'''
| |
| '''| [[Cefuroxime contraindications|Contraindications]]'''
| |
| '''| [[Cefuroxime warnings and precautions|Warnings and Precautions]]'''
| |
| '''| [[Cefuroxime adverse reactions|Adverse Reactions]]'''
| |
| '''| [[Cefuroxime overdosage|Overdosage]]'''
| |
| '''| [[Cefuroxime dosage and administration|Dosage and Administration]]'''
| |
| '''| [[Cefuroxime compatibility and stability|Compatibility and Stability]]'''
| |
| '''| [[Cefuroxime how supplied|How Supplied]]'''
| |
| '''| [[Cefuroxime labels and packages|Labels and Packages]]'''
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |
| http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/50643s11lbl.pdf
| |
| [[Category:Antibiotics]]
| |
| [[Category:Wikinfect]]
| |